Australia regenerative medicine market
is anticipated to register growth with an impressive CAGR in the forecast
period, 2023-2027, on the account of advancing medicines and growing expenses
over advancement of the pharmaceutical products. Increasing evolution in
pharmaceutical sector to design advanced drugs, and various other methods to
better the existing treatment along with finding curative medicines for the
unknown diseases, are anticipated to drive the growth of the Australia
regenerative medicine market in the upcoming five years.
Regenerative medicines are a class of
drugs that help in the process of replacing, engineering or regenerating human
cells or animal cells. The drugs help in restoring the normal functioning of
the cells. To restore the functions, regenerative medicines stimulate the
body’s own repair system to heal the irreparable tissues and organs. The
regenerative medicine has potential that can be used for artificial generation
of tissues and organs in laboratory that can later be implanted safely in case the
body is unable to heal in certain conditions. Various biomedical techniques and
clinical therapies are involved with regenerative medicine like cell therapy,
immunomodulation therapy, and tissue engineering.
Bio-medical Advances Drive Market Growth
Regenerative medicines are advanced pharmaceuticals
that undergo consistent research and product development such that better
healthcare and patient care services are provided. Biomedical methods like cell
therapy, immunomodulation therapy, and tissue engineering are increasing with
the advancement in medicine and driving the growth of the Australia
regenerative medicine market in the upcoming five years.
Moreover, increasing investment in these
biomedical procedures and their research also aid the growth of the Australia
regenerative medicine market in the next five years. Australian Government
Department of Industry, Innovation and Science have funded Cooperative Research
Center Program and amount of USD60 million through CTM CRC to develop
integrated cost effective, and accessible cell therapies that have further
revolutionized regenerative medicine.
Chronic Diseases Surges Demands For
Regenerative Medicine
Increase in the instances of various
neurological diseases and cancer, that are chronic and require advanced
medicinal approach further support the growth of the Australia regenerative
medicine market in the upcoming five years. Alzheimer’s disease, Parkinson’s
disease, cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries
are being treated with regenerative medicine and thus supporting market growth.
Also, rising geriatric population in the
country that is prone to diseases like musculoskeletal, oncological,
dermatological and cardiological disorders are aiding the growth of the
Australia regenerative medicine market in the next five years.
Click here to download the sample
Market Segmentation
The Australia regenerative
medicine market is segmented by type, application, end user, competitional
landscape, and regional distribution. Based
on type, the market is further differentiated into cell therapy, gene
modification, tissue engineering, and others. On the basis of application, the
market segment is bifurcated into bone graft substitutes, osteoarticular
diseases, dermatology, cardiovascular diseases, and others.
Market segments on
the basis of end user, is further divided between academic and commercial end
users. The market analysis also studies the regional segmentation to devise
regional market segmentation, divided among Northern territory region, New
South Wales region, Victoria region, Western Australia region, Queensland
region, Tasmania region, and the South Australia region.
Company Profile
Cell Therapies Pty Ltd., Hudson
Institute, Orthocell Ltd., Q-Gen Cell Therapeutics, Westmead Viral Vector
Facility, Sydney Cell & Gene Therapies, Auspep Holdings Ltd., Luina Bio Pty
Ltd., among others is a
partial list of major market players of the companies responsible for the
growth of Australia regenerative medicine market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered
|
·
Type
·
Application
·
End User
|
|
Regional scope
|
Northern
territory region, New South Wales region, Victoria region, Western Australia
region, Queensland region, Tasmania region, and the South Australia region.
|
|
Key companies profiled
|
Cell Therapies Pty Ltd., Hudson Institute, Orthocell Ltd.,
Q-Gen Cell Therapeutics, Westmead Viral Vector Facility, Sydney Cell &
Gene Therapies, Auspep Holdings Ltd., Luina Bio Pty Ltd.
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, Australia regenerative medicine market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
- Australia Regenerative Medicine Market,
By Type:
- Cell Therapy
- Gene Modification
- Tissue Engineering
- Others
- Australia Regenerative Medicine Market,
By Application:
- Bone Graft Substitutes
- Osteoarticular Diseases
- Dermatology
- Cardiovascular Diseases
- Others
- Australia Regenerative Medicine Market,
By End User:
- Australia Regenerative Medicine Market,
By Region:
o
Northern Territory Region
o
New South Wales Region
o
Victoria Region
o
Western Australia Region
o
Queensland Region
o
Tasmania Region
o
South Australia Region
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in Australia regenerative medicine market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of additional
market players (up to five).
Australia Regenerative
medicine Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]